advanced search  
Updated Sep. 4, 2008
 
 
 
Trastuzumab-resistant MBC Responds to Lapatinib
ISSUE: AUGUST, 2008
Lapatinib significantly improves progression-free survival (PFS) in heavily pretreated patients with human epidermal growth receptor factor 2 (HER2)- positive metastatic breast cancer who have progressed on their last trastuzumab-containing regimen, according to a recent study. read more
When Used as Maintenance Therapy, Pemetrexed Improves PFS in Patients With Advanced NSCLC
ISSUE: AUGUST, 2008
A multicenter Phase III trial has revealed that maintenance therapy with pemetrexed improved progression-free survival (PFS) in patients with advanced non-small cell lung cancer (NSCLC), according to a study presented at the annual meeting of the American Society of Clinical Oncology (abstract 8011). read more
Earlier Use of Palliative Care Services Might Increase Their Benefit
ISSUE: AUGUST, 2008
Oncologists should increase efforts to refer patients to palliative care at an earlier stage. Although awareness of palliative care may have improved, doctors are not referring patients to palliative care earlier, according to investigators at the University of Texas M.D. Anderson Cancer Center in Houston. read more
Protect Your Practice With an Annual Expense Check-Up
ISSUE: AUGUST, 2008
Increasing operating costs, declining reimbursement and tighter margins mandate that you take a closer look at your practice on a regular basis and assess your financial situation. Today, even large practices are struggling to manage expenses. Changes created by ASP+ payment and regulations on ESA usage have significantly reduced revenue for oncology practices. For diversified practices, changes in payment for diagnostic radiology and ambulatory surgery have also placed stress on practice resources. We anticipate that payment reductions for radiation will follow. read more
 
 
 
JUNE, 2008
Renal Cell Carcinoma: State-of-the-Art Diagnosis and Treatment
Treatment of Advanced Non–Small Cell Lung Cancer: First-line Therapy a
Guide for the Administration and Use of Cancer Therapeutic Agents 2008
Management Of Breast Cancer: Advanced Disease and Novel Agents
Treatment of Advanced Non–Small Cell Lung Cancer: Second-line Therapy
more  
 




•  The Medical Treatment of Metastatic Colorectal Cancer

•  The Book Page - August 2008

•  Highlights From ASCO

•  Can Your Practice Afford Not To Hire a Clinical Pharmacist?

•  Cetuximab Improves Survival In Late-Stage NSCLC

•  Trastuzumab-resistant MBC Responds to Lapatinib

•  In Colon Cancer Patients …KRAS Mutation Testing a Must Before EGFR Blo

•  When Used as Maintenance Therapy, Pemetrexed Improves PFS in Patients

•  Can “Patient Frequent Flyer” Program Improve Health Care?

•  In Women With Breast Cancer …Zoledronic Acid Increases DFS, RFS

 
EDUCATIONAL REVIEW
Goals of Therapy and Current Challenges in Chronic Myelogenous Leukemia
SOLID TUMORS
When Used as Maintenance Therapy, Pemetr...  [8/2008] (new)
Trastuzumab-resistant MBC Responds to La...  [8/2008] (new)
PET-CT Scanner Shines in Head and Neck C...  [8/2008] (new)
more 
SYMPTOM CONTROL /
PALLIATIVE CARE
Earlier Use of Palliative Care Services ...  [8/2008] (new)
Vitamin D Deficiency Linked to Worse Prognosis in ...  [7/2008]
Denosumab Boosts Bone Density in Women Receiving A...  [5/2008]
more 

AUGUST, 2008
FREE PRINT SUBSCRIPTION
 
 
 
 
home  |  about us  |  advertise  |  contact  |  publications
 


Copyright ?2005 - 2008 McMahon Publishing unless otherwise noted.
All rights reserved. Reproduction in whole or in part without permission is prohibited.